Literature DB >> 11755638

PTEN mutations and proteus syndrome.

L G Biesecker, M J Rosenberg, S Vacha, J T Turner, M M Cohen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11755638     DOI: 10.1016/S0140-6736(01)07109-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Detection of clinically relevant exonic copy-number changes by array CGH.

Authors:  Philip M Boone; Carlos A Bacino; Chad A Shaw; Patricia A Eng; Patricia M Hixson; Amber N Pursley; Sung-Hae L Kang; Yaping Yang; Joanna Wiszniewska; Beata A Nowakowska; Daniela del Gaudio; Zhilian Xia; Gayle Simpson-Patel; LaDonna L Immken; James B Gibson; Anne C-H Tsai; Jennifer A Bowers; Tyler E Reimschisel; Christian P Schaaf; Lorraine Potocki; Fernando Scaglia; Tomasz Gambin; Maciej Sykulski; Magdalena Bartnik; Katarzyna Derwinska; Barbara Wisniowiecka-Kowalnik; Seema R Lalani; Frank J Probst; Weimin Bi; Arthur L Beaudet; Ankita Patel; James R Lupski; Sau Wai Cheung; Pawel Stankiewicz
Journal:  Hum Mutat       Date:  2010-11-02       Impact factor: 4.878

2.  Assessment of PTEN-associated vascular malformations in a patient with Bannayan-Riley-Ruvalcaba syndrome.

Authors:  Sandra Anusic; Robert Karl Josef Clemens; Thomas Oleg Meier; Beatrice Ruth Amann-Vesti
Journal:  BMJ Case Rep       Date:  2016-06-29

3.  A mosaic activating mutation in AKT1 associated with the Proteus syndrome.

Authors:  Marjorie J Lindhurst; Julie C Sapp; Jamie K Teer; Jennifer J Johnston; Erin M Finn; Kathryn Peters; Joyce Turner; Jennifer L Cannons; David Bick; Laurel Blakemore; Catherine Blumhorst; Knut Brockmann; Peter Calder; Natasha Cherman; Matthew A Deardorff; David B Everman; Gretchen Golas; Robert M Greenstein; B Maya Kato; Kim M Keppler-Noreuil; Sergei A Kuznetsov; Richard T Miyamoto; Kurt Newman; David Ng; Kevin O'Brien; Steven Rothenberg; Douglas J Schwartzentruber; Virender Singhal; Roberto Tirabosco; Joseph Upton; Shlomo Wientroub; Elaine H Zackai; Kimberly Hoag; Tracey Whitewood-Neal; Pamela G Robey; Pamela L Schwartzberg; Thomas N Darling; Laura L Tosi; James C Mullikin; Leslie G Biesecker
Journal:  N Engl J Med       Date:  2011-07-27       Impact factor: 91.245

Review 4.  The complexes of mammalian target of rapamycin.

Authors:  Hongyu Zhou; Shile Huang
Journal:  Curr Protein Pept Sci       Date:  2010-09       Impact factor: 3.272

5.  Germline PTEN mutations are rare and highly penetrant.

Authors:  Cecilie F Rustad; Merete Bjørnslett; Ketil R Heimdal; Lovise Mæhle; Jaran Apold; Pål Møller
Journal:  Hered Cancer Clin Pract       Date:  2006-12-15       Impact factor: 2.857

Review 6.  PTEN hamartoma tumor syndromes.

Authors:  Gideon M Blumenthal; Phillip A Dennis
Journal:  Eur J Hum Genet       Date:  2008-09-10       Impact factor: 4.246

Review 7.  Overgrowth syndromes - clinical and molecular aspects and tumour risk.

Authors:  Frédéric Brioude; Annick Toutain; Eloise Giabicani; Edouard Cottereau; Valérie Cormier-Daire; Irene Netchine
Journal:  Nat Rev Endocrinol       Date:  2019-05       Impact factor: 43.330

8.  De Novo PTEN Mutation in a Young Boy with Cutaneous Vasculitis.

Authors:  Angela Mauro; Ebun Omoyinmi; Neil James Sebire; Angela Barnicoat; Paul Brogan
Journal:  Case Rep Pediatr       Date:  2017-04-24

9.  Proteus syndrome: report of intra-abdominal lipomatosis.

Authors:  Basak Erginel; Melih Akin; Abdullah Yildiz; Cetin Karadag; Nihat Sever; Canan Tanik; Mehmet Erturk; Ali Ihsan Dokucu
Journal:  European J Pediatr Surg Rep       Date:  2013-04-20

10.  Distinguishing between PTEN clinical phenotypes through mutation analysis.

Authors:  Stephanie Portelli; Lucy Barr; Alex G C de Sá; Douglas E V Pires; David B Ascher
Journal:  Comput Struct Biotechnol J       Date:  2021-05-21       Impact factor: 7.271

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.